Kui Luo
University of Science and Technology of China(CN)Walmart (United States)(US)Agilent Technologies (United States)(US)North China Electric Power University(CN)City College of San Francisco(US)Hefei University of Technology(CN)Massachusetts College of Pharmacy and Health Sciences(US)University of New Mexico(US)Capital Medical University(CN)Yunnan University(CN)Xiamen University(CN)Chinese Academy of Sciences(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Sichuan University(CN)Guilin University of Technology(CN)First Affiliated Hospital of Xiamen University(CN)West China Hospital of Sichuan University(CN)Zhongshan Hospital of Xiamen University(CN)Chengdu Institute of Biology(CN)Sichuan Academy of Traditional Chinese Medicine(CN)Zhejiang Mariculture Research Institute(CN)State Key Laboratory of BiotherapyChina Electric Power Research Institute
Publications by Year
Research Areas
Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, Dendrimers and Hyperbranched Polymers, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency(2022)620 cited
- → Preparation and application of pH-responsive drug delivery systems(2022)531 cited
- → Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking(2013)478 cited
- → The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron–doxorubicin conjugates for cancer therapy(2012)271 cited
- → Dendronized heparin−doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy(2013)255 cited
- → Artificial intelligence aids in development of nanomedicines for cancer management(2023)224 cited